Impact of ivabradine in decompensated heart failure due to cancer therapy‐related cardiac dysfunction

Impact of ivabradine in decompensated heart failure due to cancer therapy‐related cardiac dysfunction

Key Clinical Message In cases of decompensated heart failure related to cancer therapy‐related cardiac dysfunction, ivabradine administration could lead to an increased stroke volume by reducing the sinus heart rate, resulting in favorable hemodynamics. Assessment of the overlap between the E‐ and A...

Full description

Bibliographic Details
Main Authors: Yusuke Nakano, Hirohiko Ando, Wataru Suzuki, Hirofumi Ohashi, Yasushi Suzuki, Hiroaki Takashima, Tetsuya Amano
Format: Article
Language:English
Published: Wiley 2021-05-01
Series:Clinical Case Reports
Subjects:
A wave
anthracycline
cancer
CTRCD
decompensated heart failure
E wave
Online Access:https://doi.org/10.1002/ccr3.4133

Internet

https://doi.org/10.1002/ccr3.4133

Similar Items